NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000241

Registered date:22/09/2005

Research on influenza vaccine immunogencity in infants.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedinfluenza
Date of first enrollment2005/10/01
Target sample size200
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Influenza HA vaccine is inoculated twice at 4 weeks interval. Side reaction survey at 48hours after vaccination and survey during epidemics of influenza are conducted. Inoculated dose: 0.1 mL for infants <1 year of age. 0.2mL for infants 1-3years of age.

Outcome(s)

Primary OutcomeHI titers before and after vaccination.
Secondary OutcomeSurvey on side reaction after vaccination. Survey during epidemics of influenza.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximum4years-old
GenderMale and Female
Include criteria
Exclude criteria1.Infants with a fever at the time of planned vaccination. 2.Infants with serious acute diseases. 3.Infants who has induced anaphylaxis by the substances of the vaccine. 4.Infants considered inappropriate to be inoculated vaccine.

Related Information

Contact

public contact
Name Shin Irie
Address Japan
Telephone 092-733-1001
E-mail
Affiliation Medical Co. LTA Kyusyu Clinical Pharmacology Research Clinic Clinical Pharmacology Department
scientific contact
Name Shin Irie
Address 2-13-16 Jigyo Chuo-ku, Fukuoka Japan
Telephone 092-733-1001
E-mail
Affiliation Medical Co. LTA Kyusyu Clinical Pharmacology Research Clinic Clinical Pharmacology Department